417
Views
6
CrossRef citations to date
0
Altmetric
Articles

Bladder health in patients treated with BCG instillations for T1G2-G3 bladder cancer – a follow-up five years after the start of treatment

ORCID Icon, , , , &
Pages 377-384 | Received 14 May 2018, Accepted 13 Oct 2018, Published online: 08 Jan 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Lauren J Lee, Christina S Kwon, Anna Forsythe, Carla M Mamolo, Elizabeth T Masters & Ira A Jacobs. (2020) Humanistic and Economic Burden of Non-Muscle Invasive Bladder Cancer: Results of Two Systematic Literature Reviews. ClinicoEconomics and Outcomes Research 12, pages 693-709.
Read now
Wojciech Krajewski, Sławomir Poletajew, Romuald Zdrojowy & Anna Kołodziej. (2019) Complications after BCG immunotherapy – neither a mountain nor a molehill. Scandinavian Journal of Urology 53:4, pages 265-266.
Read now

Articles from other publishers (4)

John W. Yuen, Ricky W. Wu, Shirley S. Ching & Chi-Fai Ng. (2022) Impact of Effective Intravesical Therapies on Quality of Life in Patients with Non-Muscle Invasive Bladder Cancer: A Systematic Review. International Journal of Environmental Research and Public Health 19:17, pages 10825.
Crossref
Marko Babjuk, Maximilian Burger, Otakar Capoun, Daniel Cohen, Eva M. Compérat, José L. Dominguez Escrig, Paolo Gontero, Fredrik Liedberg, Alexandra Masson-Lecomte, A. Hugh Mostafid, Joan Palou, Bas W.G. van Rhijn, Morgan Rouprêt, Shahrokh F. Shariat, Thomas Seisen, Viktor Soukup & Richard J. Sylvester. (2022) European Association of Urology Guidelines on Non–muscle-invasive Bladder Cancer (Ta, T1, and Carcinoma in Situ). European Urology 81:1, pages 75-94.
Crossref
Claudia Rutherford, Manish I. Patel, Margaret-Ann Tait, David P. Smith, Daniel S. J. Costa, Shomik Sengupta & Madeleine T. King. (2020) Patient-reported outcomes in non-muscle invasive bladder cancer: a mixed-methods systematic review. Quality of Life Research 30:2, pages 345-366.
Crossref
Wei‐Bo Yu & Jian‐Yu Rao. (2019) Programmed death ligand‐1/programmed death‐1 inhibition therapy and programmed death ligand‐1 expression in urothelial bladder carcinoma. Chronic Diseases and Translational Medicine 5:3, pages 170-177.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.